about
Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in MiceStructure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoireOne-pot, mix-and-read peptide-MHC tetramersAdaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccinationMHC class II epitope predictive algorithms.The peptide-binding specificity of HLA-A*3001 demonstrates membership of the HLA-A3 supertype.Selecting informative data for developing peptide-MHC binding predictors using a query by committee approach.A community resource benchmarking predictions of peptide binding to MHC-I molecules.Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction.HIV subtype influences HLA-B*07:02-associated HIV disease outcome.Use of "one-pot, mix-and-read" peptide-MHC class I tetramers and predictive algorithms to improve detection of cytotoxic T lymphocyte responses in cattle.Description and prediction of peptide-MHC binding: the 'human MHC project'.Identification of CD8+ T cell epitopes in the West Nile virus polyprotein by reverse-immunology using NetCTL.HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.Porcine major histocompatibility complex (MHC) class I molecules and analysis of their peptide-binding specificitiesT cells recognizing a peptide contaminant undetectable by mass spectrometry.Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donorsProgrammed death-1 expression on HIV-1-specific CD8+ T cells is shaped by epitope specificity, T-cell receptor clonotype usage and antigen load.Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendationsSensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach.NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure.Identification of peptides from foot-and-mouth disease virus structural proteins bound by class I swine leukocyte antigen (SLA) alleles, SLA-1*0401 and SLA-2*0401.Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination.Identification and mapping of linear antibody epitopes in human serum albumin using high-density Peptide arrays.T cell-mediated hypersensitivity reactions to drugsDifferent binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoiresCD8+ T cells complement antibodies in protecting against yellow fever virus.CD8+ TCR Bias and Immunodominance in HIV-1 Infection.HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune controlDifferential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccineExtensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIVHLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vecMHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination.Major histocompatibility complex class I binding predictions as a tool in epitope discovery.Designing bovine T cell vaccines via reverse immunology.
P50
Q27303766-5A0A78B5-56BE-4DE8-9F61-5D3AB482D32EQ27650782-87B6D850-C02E-4F54-A558-C6D7B40FF1FEQ27679355-48259B7F-72F1-47BF-A801-1104575EE0D0Q28472228-DBE48C02-5CA3-45A0-918D-809C65644718Q29274569-1A2EF672-2D98-49F8-A19F-773205B08893Q30388353-D68492DA-6A57-495F-9165-D696A6C23E6DQ30847569-CCDF7A7F-242D-45C9-9782-0A1F9347203AQ30884495-94C0E519-934F-46A2-9626-516A56B84815Q33247448-C812163B-7EA3-40C4-AB39-CE14610D4EBEQ33304572-245C90C9-4D97-4FF2-A889-855FC564102DQ33566546-D991E180-1FC4-46ED-A1BD-0EB4D1D27F6BQ33602365-1957DC49-BFD7-4E53-B2DB-55CE6A520227Q33632439-E4B11080-EBBD-4FD1-B7F6-6C818344ABF4Q33697909-BEE412AB-33CF-4176-A273-E1E3FBEC0CFAQ33755226-DDD0ED66-702D-40FD-9354-8FDA92E9534DQ33955589-B4A9948A-2D10-49EA-949D-FC7ED6ACB674Q34110455-15B851CC-1A10-4AF5-BE2F-A6819BFC93C6Q34162822-33E12037-C21F-4DEF-9C8A-748388C29B96Q34197037-3470274B-F855-47E9-9CAF-3869170748EAQ34245542-C79520B0-79FE-4834-AD24-FC2EFF85759CQ34276766-C7F27E35-D1C2-4B3B-9AE5-A19F6E28A365Q34366463-41E884B5-3C81-4F3F-B606-EA7AD95EA527Q34416556-3A301C3B-CAA9-47EA-8027-15E8489D806EQ34738886-F9ABEFEE-DA64-4DCF-A437-B57CA47B505DQ34873592-2A8118F6-3CA8-4A37-A741-26908D604839Q34971993-01EABF2D-0BE3-4D88-B88B-BA203DD8B8B5Q34978613-B9C8876E-A7FE-4B85-87FF-801D81C33D73Q34980404-9ABF0C1C-F46C-46B5-A28C-3718BDA0D66AQ35613273-FEB43D8D-7BC2-49AC-9BCD-47252438842BQ35665876-FFD8406E-DB65-4B4A-97C8-583E86928A39Q36397593-5A107B25-EFF4-4AE7-8459-15BE93D07F17Q36467153-C453AD66-8560-4D39-A0C0-473CDE41DFAEQ36601101-1E089A50-8F55-4FA2-83DD-BB41F4F6D141Q36807094-AD8D2C90-764E-40C3-A758-E6A671EB3D9CQ36910003-B09AD709-038D-4FB3-BA84-6B3EDCD29966Q37081581-6747D6D4-E92D-4A00-A20D-08ADE26E81B6Q37285734-A9FA6EB6-6F6D-4EE3-AD2F-1089D82F89E7Q37443937-FE278344-C944-4745-8AC1-099BA708DE8DQ37762296-215F3AD6-A82C-42E8-BA44-A820A3ADA740Q38012550-BD51A930-5D77-4E7F-985B-C7D8EF8C4E37
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Soren Buus
@ast
Soren Buus
@en
Soren Buus
@es
Soren Buus
@nl
Soren Buus
@sl
Søren Buus
@da
Søren Buus
@de
type
label
Soren Buus
@ast
Soren Buus
@en
Soren Buus
@es
Soren Buus
@nl
Soren Buus
@sl
Søren Buus
@da
Søren Buus
@de
altLabel
Buus S
@en
Buus S.
@en
Buus
@en
S Buus
@en
S. Buus
@en
Soren Buus
@da
Sören Buus
@de
Søren Buus
@en
prefLabel
Soren Buus
@ast
Soren Buus
@en
Soren Buus
@es
Soren Buus
@nl
Soren Buus
@sl
Søren Buus
@da
Søren Buus
@de
P106
P1153
55625990000
P21
P2456
P31
P496
0000-0001-8363-1999